Literature DB >> 15137060

HER2 signaling enhances 5'UTR-mediated translation of c-Myc mRNA.

Enrico Galmozzi1, Patrizia Casalini, Marilena Valeria Iorio, Barbara Casati, Clelia Olgiati, Sylvie Ménard.   

Abstract

The increased levels of c-Myc protein observed previously in an ovarian carcinoma cell line stably transfected to express HER2 has suggested a role for the HER2 pathway in c-Myc expression. Analysis of HER2-transfected cells stimulated with heregulin beta1 (HRG) revealed increased c-Myc protein levels but not a corresponding increase in c-Myc mRNA expression or any change in c-Myc protein half-life. Transfection of HER2-overexpressing cells with a construct containing the 5' untranslated region (5'UTR) of c-Myc mRNA originated from the P2 promoter and placed upstream of the Renilla luciferase gene, enhanced reporter expression upon stimulation with HRG. The HRG-mediated increase in reporter activity correlated with the HRG-mediated induction observed for c-Myc protein, identifying the P2-derived leader (P2L) of c-Myc mRNA as the cis-element involved in c-Myc translational induction. Both the increase in c-Myc protein levels and P2L-enhanced translational activity were inhibited by the PI3K inhibitor wortmannin. Together, these results demonstrate that HRG stimulation of HER2 overexpressing cells leads to enhanced c-Myc protein synthesis through activation of the PI3K/Akt/mTOR pathway and that the P2L of c-Myc mRNA is the element responsible for induction of c-Myc translation. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15137060     DOI: 10.1002/jcp.20012

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  19 in total

1.  Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneity.

Authors:  Tyler Risom; Xiaoyan Wang; Juan Liang; Xiaoli Zhang; Carl Pelz; Lydia G Campbell; Jenny Eng; Koei Chin; Caroline Farrington; Goutham Narla; Ellen M Langer; Xiao-Xin Sun; Yulong Su; Colin J Daniel; Mu-Shui Dai; Christiane V Löhr; Rosalie C Sears
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

2.  mrtl-A translation/localization regulatory protein encoded within the human c-myc locus and distributed throughout the endoplasmic and nucleoplasmic reticular network.

Authors:  Hyoungsoo Choi; Nateka L Jackson; Denise R Shaw; Peter D Emanuel; Y Lucy Liu; Albert Tousson; Zheng Meng; Scott W Blume
Journal:  J Cell Biochem       Date:  2008-11-01       Impact factor: 4.429

3.  An Epigenetic Pathway Regulates Sensitivity of Breast Cancer Cells to HER2 Inhibition via FOXO/c-Myc Axis.

Authors:  Smita Matkar; Paras Sharma; Shubin Gao; Buddha Gurung; Bryson W Katona; Jennifer Liao; Abdul Bari Muhammad; Xiang-Cheng Kong; Lei Wang; Guanghui Jin; Chi V Dang; Xianxin Hua
Journal:  Cancer Cell       Date:  2015-10-12       Impact factor: 31.743

4.  Activation and up-regulation of translation initiation factor 4B contribute to arsenic-induced transformation.

Authors:  Yong Zhang; Qing Wang; Xiaoling Guo; Robert Miller; Yinglu Guo; Hsin-Sheng Yang
Journal:  Mol Carcinog       Date:  2011-01-25       Impact factor: 4.784

5.  Control of cell survival and proliferation by mammalian eukaryotic initiation factor 4B.

Authors:  David Shahbazian; Armen Parsyan; Emmanuel Petroulakis; Ivan Topisirovic; Yvan Martineau; Bernard F Gibbs; Yuri Svitkin; Nahum Sonenberg
Journal:  Mol Cell Biol       Date:  2010-01-19       Impact factor: 4.272

6.  Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1alpha/Sp4.

Authors:  Wen-Bin Tsai; Isamu Aiba; Soo-yong Lee; Lynn Feun; Niramol Savaraj; Macus Tien Kuo
Journal:  Mol Cancer Ther       Date:  2009-12       Impact factor: 6.261

7.  Immunotherapy with dendritic cells and cytokine-induced killer cells for MDA-MB-231 breast cancer stem cells in nude mice.

Authors:  Qiang Chen; Xiao-Xu Cui; Pei-Fen Liang; Jin-Xia Dou; Zi-Yan Liu; Wen-Wen Sun
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

Review 8.  Targeting prostate cancer based on signal transduction and cell cycle pathways.

Authors:  John T Lee; Brian D Lehmann; David M Terrian; William H Chappell; Franca Stivala; Massimo Libra; Alberto M Martelli; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2008-06-16       Impact factor: 4.534

9.  Nucleoside diphosphate kinase B promotes osteosarcoma proliferation through c-Myc.

Authors:  Shijie Li; Tu Hu; Ting Yuan; Dongdong Cheng; Qingcheng Yang
Journal:  Cancer Biol Ther       Date:  2018-04-13       Impact factor: 4.742

10.  Inhibition of eIF2alpha dephosphorylation inhibits ErbB2-induced deregulation of mammary acinar morphogenesis.

Authors:  Sharon J Sequeira; Huei Chi Wen; Alvaro Avivar-Valderas; Eduardo F Farias; Julio A Aguirre-Ghiso
Journal:  BMC Cell Biol       Date:  2009-09-15       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.